BCAXHealthcareSmall-Cap
Bicara Therapeutics Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Bicara Therapeutics Inc. (BCAX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are BCAX insiders buying or selling?
Bicara Therapeutics Inc. insiders reported 3 open-market buys ($39.1M) and 38 sells ($11.7M) across 41 Form 4 filings — a net buying position of $27.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 14, 2026)
Total Form 4 filings
41
SEC EDGAR
Insider filers
7
Insider buys (3)
$39.1M
Insider sells (38)
$11.7M
Insider sentiment
Net buyingNet insider flow of $27.3M in net buying.
Recent BCAX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Claire Mazumdar | Chief Executive Officer | Sale | 10.0K | $28.42 | $284.2K |
| May 26, 2026 | Ivan Hyep | Chief Financial Officer | Sale | 9.2K | $20.42 | $187.9K |
| May 20, 2026 | Claire Mazumdar | Chief Executive Officer | Sale | 15.0K | $20.04 | $300.6K |
| May 18, 2026 | Ryan Cohlhepp | President and COO | Sale | 12.5K | $20.29 | $253.6K |
| Apr 28, 2026 | David Raben | Chief Medical Officer | Sale | 5.5K | $22.88 | $125.8K |
| Apr 22, 2026 | Ivan Hyep | Chief Financial Officer | Sale | 9.2K | $23.00 | $211.6K |
| Apr 20, 2026 | Claire Mazumdar | Chief Executive Officer | Sale | 15.0K | $23.61 | $354.1K |
| Apr 17, 2026 | Ryan Cohlhepp | President and COO | Sale | 12.5K | $23.01 | $287.6K |
| Mar 26, 2026 | David Raben | Chief Medical Officer | Sale | 5.5K | $18.95 | $104.2K |
| Mar 24, 2026 | Ivan Hyep | Chief Financial Officer | Sale | 9.2K | $18.52 | $170.3K |
| Mar 20, 2026 | Claire Mazumdar | Chief Executive Officer | Sale | 15.0K | $18.82 | $282.4K |
| Mar 17, 2026 | Ryan Cohlhepp | President and COO | Sale | 12.5K | $19.66 | $245.7K |
| Mar 11, 2026 | Claire Mazumdar | Chief Executive Officer | Sale | 36.8K | $19.17 | $704.7K |
| Mar 7, 2026 | Claire Mazumdar | Chief Executive Officer | Sale | 8.2K | $18.74 | $154.3K |
| Mar 6, 2026 | Ryan Cohlhepp | President and COO | Sale | 17.4K | $18.16 | $315.9K |
| Mar 6, 2026 | Ivan Hyep | Chief Financial Officer | Sale | 16.5K | $18.22 | $301.0K |
| Mar 6, 2026 | David Raben | Chief Medical Officer | Sale | 16.5K | $18.52 | $305.6K |
| Mar 2, 2026 | Peter Kolchinsky | Director, 10% Owner | Purchase | 300.0K | $16.00 | $4.8M |
| Feb 27, 2026 | Ryan Cohlhepp | President and COO | Sale | 3.6K | $18.04 | $65.5K |
| Jan 26, 2026 | Ryan Cohlhepp | President and COO | Sale | 3.8K | $18.10 | $69.3K |
| Jan 26, 2026 | Ivan Hyep | Chief Financial Officer | Sale | 1.9K | $18.15 | $34.2K |
| Jan 20, 2026 | Ryan Cohlhepp | President and COO | Sale | 149 | $18.02 | $2.7K |
| Dec 23, 2025 | Ivan Hyep | Chief Financial Officer | Sale | 9.2K | $18.31 | $168.5K |
| Dec 16, 2025 | Ryan Cohlhepp | President and COO | Sale | 12.5K | $18.68 | $233.5K |
| Nov 25, 2025 | Ivan Hyep | Chief Financial Officer | Sale | 18.4K | $18.54 | $341.1K |
Showing the 25 most recent of 41 Form 4 filings for Bicara Therapeutics Inc..
Most active BCAX insiders
- Ryan Cohlhepp11 filings
- Claire Mazumdar9 filings
- Ivan Hyep9 filings
- David Raben5 filings
- Lara Meisner4 filings
Ask anything about BCAX insider activity
Use Trabud's AI agent to query Bicara Therapeutics Inc.'s Form 4 history in plain English — "Show me BCAX CEO purchases this year" or compare it against any other ticker.
Open the AI agentBCAX insider trading FAQ
Are Bicara Therapeutics Inc. insiders buying or selling?
Across 41 SEC Form 4 filings, Bicara Therapeutics Inc. (BCAX) insiders reported 3 open-market purchases totaling $39.1M and 38 sales totaling $11.7M. That is a net buying position of $27.3M.
How many insiders trade BCAX stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Bicara Therapeutics Inc.. The most recent filing was accepted on Jul 14, 2026.
Where does Trabud get BCAX insider trading data?
All BCAX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.